These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23037522)

  • 21. [Effect of landiolol hydrochloride for intraoperative tachycardia--multicenter questionnaire study].
    Ohsuda M; Edanaga M; Mimura M; Nakayama Y; Kirita A; Koro S; Yamaya K; Kurihara M; Yamakage M
    Masui; 2012 Feb; 61(2):159-63. PubMed ID: 22413438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
    Nakano T; Shimizu K; Kawashima O; Kamiyoshihara M; Nagashima T; Ibe T; Takeyoshi I
    J Clin Pharm Ther; 2012 Aug; 37(4):431-5. PubMed ID: 22059486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Landiolol Hydrochloride Rapidly Controls Junctional Ectopic Tachycardia After Pediatric Heart Surgery.
    Yoneyama F; Tokunaga C; Kato H; Nakajima T; Mathis BJ; Sakamoto H; Hiramatsu Y
    Pediatr Crit Care Med; 2018 Aug; 19(8):713-717. PubMed ID: 29677032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of two different landiolol formulations in a healthy Caucasian group.
    Krumpl G; Ulc I; Trebs M; Kadlecová P; Hodisch J
    Eur J Pharm Sci; 2016 Sep; 92():64-73. PubMed ID: 27373605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of landiolol hydrochloride after off-pump coronary artery bypass.
    Maisawa K; Yamazaki K; Ishitoya H; Shimamura Y
    Asian Cardiovasc Thorac Ann; 2013 Apr; 21(2):170-5. PubMed ID: 24532615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of landiolol in attenuating hemodynamic responses to local epinephrine infiltration in patients undergoing vaginal total hysterectomy.
    Hirota K; Baba S; Fukushi S; Muraoka M; Matsuki A
    J Anesth; 2005; 19(1):17-20. PubMed ID: 15674510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of landiolol on hemodynamic response and seizure duration during electroconvulsive therapy.
    Nomoto K; Suzuki T; Serada K; Oe K; Yoshida T; Yamada S
    J Anesth; 2006; 20(3):183-7. PubMed ID: 16897237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, pharmacodynamics, and safety of landiolol hydrochloride in healthy Chinese subjects.
    Wang M; Zhang Q; Hua W; Zhou W; Huang M; Wang H
    Drug Res (Stuttg); 2014 Mar; 64(3):141-5. PubMed ID: 24002929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group.
    Krumpl G; Ulc I; Trebs M; Kadlecová P; Hodisch J
    Eur J Clin Pharmacol; 2017 Apr; 73(4):417-428. PubMed ID: 28091703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study).
    Nagai R; Kinugawa K; Inoue H; Atarashi H; Seino Y; Yamashita T; Shimizu W; Aiba T; Kitakaze M; Sakamoto A; Ikeda T; Imai Y; Daimon T; Fujino K; Nagano T; Okamura T; Hori M;
    Circ J; 2013; 77(4):908-16. PubMed ID: 23502991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.
    Kakihana Y; Nishida O; Taniguchi T; Okajima M; Morimatsu H; Ogura H; Yamada Y; Nagano T; Morishima E; Matsuda N;
    Lancet Respir Med; 2020 Sep; 8(9):863-872. PubMed ID: 32243865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost minimization analysis of beta-blocker at the time of CT imaging for suspected of coronary heart disease in Japan.
    Igarashi A; Fujito K; Hirano M; Fukuda T
    J Med Econ; 2014 Feb; 17(2):142-7. PubMed ID: 24351028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs.
    Miwa Y; Ikeda T; Mera H; Miyakoshi M; Hoshida K; Yanagisawa R; Ishiguro H; Tsukada T; Abe A; Yusu S; Yoshino H
    Circ J; 2010 May; 74(5):856-63. PubMed ID: 20339194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of landiolol for suppressing the hyperdynamic response following laryngoscopy and tracheal intubation: a systematic review.
    Inoue S; Tanaka Y; Kawaguchi M; Furuya H
    Anaesth Intensive Care; 2009 Nov; 37(6):893-902. PubMed ID: 20014594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol.
    Sasao J; Tarver SD; Kindscher JD; Taneyama C; Benson KT; Goto H
    Can J Anaesth; 2001 Nov; 48(10):985-9. PubMed ID: 11698317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature.
    Matsuishi Y; Mathis BJ; Shimojo N; Kawano S; Inoue Y
    Vasc Health Risk Manag; 2020; 16():111-123. PubMed ID: 32308404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of ivabradin to reduce heart rate prior to coronary CT angiography: comparison with beta-blocker.
    Bayraktutan U; Kantarci M; Gundogdu F; Demirelli S; Yuce I; Oğul H; Duran C; Taş H; Şimşek Z; Karabulut N
    Diagn Interv Radiol; 2012; 18(6):537-41. PubMed ID: 22729428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of landiolol, a short-acting beta-1 blocker, on hemodynamic variables during emergence from anesthesia and tracheal extubation in elderly patients with and without hypertension.
    Miyazaki M; Kadoi Y; Saito S
    J Anesth; 2009; 23(4):483-8. PubMed ID: 19921354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: Prevention of Atrial Fibrillation After Cardiac Surgery With Landiolol Hydrochloride for Left Ventricular Dysfunction (PLATON) trial.
    Sezai A; Osaka S; Yaoita H; Ishii Y; Arimoto M; Hata H; Shiono M
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):957-64. PubMed ID: 26254752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of landiolol hydrochloride on intractable tachyarrhythmia after pediatric cardiac surgery.
    Tokunaga C; Hiramatsu Y; Kanemoto S; Takahashi-Igari M; Abe M; Horigome H; Sakakibara Y
    Ann Thorac Surg; 2013 May; 95(5):1685-8. PubMed ID: 23506630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.